Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that are implicated in the pathophysiology … Continue reading →

NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai Gozani, M.D., Ph.D., and NeuroMetrix’spresident … Continue reading →

NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage compound to treat the one-third … Continue reading →

NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral diseases: viz. seasonal and potentially-epidemic … Continue reading →

Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based ink products, which are complementary … Continue reading →

Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy and vaccines. … Continue reading →

MicroVision, Inc. (NASDAQ: MVIS) is a world leader in the innovation of a new generation of display technology. The company opens up a world of possibilities by bringing enhanced visibility to the world of mobility. All the freedom and flexibility … Continue reading →

Merus Labs International, Inc. (NASDAQ: MSLI) is on a quest to become a leading specialty pharmaceutical company with a diverse line of products in key global markets, with special geographic focus on North America and Europe. The Merus strategy is … Continue reading →

Medovex Corporation (NASDAQ: MDVX) is a company dedicated to its mission of “better living through better medicine.” The highly successful and experienced healthcare executives at Medovex have a proven track record of building successful medical device and biotech companies, and … Continue reading →

MDxHealth SA (OTCBB: MXDH) is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of the company’s ConfirmMDx for Prostate Cancer testing solution within the U.S. urology community has … Continue reading →